In CLL, several studies have identified soluble NKG2D ligands in patient serum, with MICA, MICB, and ULBP2 being the most commonly upregulated [110,111,121,141]. The gene discussed is ULBP2; the disease is B-cell chronic lymphocytic leukemia.